Advances in breast cancer imaging have transformed diagnosis, but translating that information into precise surgical action remains a critical challenge. At Cairn Surgical, we set out to bridge this gap by combining patient-specific supine MRI, interactive 3D visualization, and customized surgical guidance. Technologies such as the Visualizer™ and Breast Cancer Locator (BCL™) System give surgeons a more intuitive and accurate understanding of a tumor’s size, shape, and location as it will appear during surgery. By bringing imaging, surgical planning, and intraoperative guidance together, this approach is helping move breast-conserving surgery toward a future defined by greater precision, personalization, and confidence—with the ultimate goal of improving outcomes while reducing the need for repeat procedures.

I’m proud to share my professional biography, reflecting my journey as a surgeon, educator, and healthcare innovator. Over the past two decades, I’ve worked to advance surgical care, mentor future physicians, and collaborate with medical technology pioneers to improve patient outcomes worldwide. My passion lies in transforming healthcare through action, innovation, and collaboration.

Ken Arnold is an accomplished medical device executive recognized for leading breakthrough innovations in laser technology and transforming companies through strategic vision and hands-on leadership. As CEO and Co-founder of Precise Light Surgical, he raised $17 million and guided the company from concept to commercialization with a novel tissue-sparing microsurgical platform. His earlier roles at Laserscope and Iridex underscore a consistent track record of scaling innovation into clinical and commercial success, including driving a $715 million acquisition and spearheading next-generation glaucoma treatments. With deep technical expertise, strong investor and clinical relationships, and a relentless focus on patient impact, Ken has built a career defined by precision, performance, and purpose.